You can employ fundamental analysis to find out if Mylan N V is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found thirty-six available fundamentals for Mylan N which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Mylan N V fundamentals including its Price to Book, Current Ratio, Retained Earnings, as well as the relationship between Net Income and Price to Earnings To Growth . Given that Mylan N V has Number of Shares Shorted of 8.55M, we recommend you check Mylan N last-minute market performance to make sure the company can sustain itself down the road. Use Mylan N to protect your portfolios against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Mylan N to be traded at $18.65 in 30 days.
Mylan N Company Summary
Mylan N competes with Elanco Animal, Endo International, ESSA Pharma, and Evoke Pharma. Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter pharmaceutical products in North America, Europe, and internationally. The company was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Mylan N operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 35000 people.
Mylan N Price to Earnings To Growth vs Cash per Share
Mylan N V is regarded second in price to earnings to growth category among related companies. It is regarded fourth in cash per share category among related companies fabricating about 0.59 of Cash per Share per Price to Earnings To Growth. The ratio of Price to Earnings To Growth to Cash per Share for Mylan N V is roughly 1.69
|Price to Earnings To Growth ( times )|
|Cash per Share ( times )|
Mylan N V Systematic Risk
Mylan N Thematic Clasifications
Mylan N May 24, 2019 Opportunity Range